Your browser doesn't support javascript.
loading
C-type natriuretic peptide improves growth retardation in a mouse model of cardio-facio-cutaneous syndrome.
Inoue, Shin-Ichi; Morozumi, Naomi; Yoshikiyo, Kazunori; Maeda, Hiroaki; Aoki, Yoko.
Affiliation
  • Inoue SI; Department of Medical Genetics, Tohoku University School of Medicine, Sendai.
  • Morozumi N; Immunology and Inflammatory Disease Field, Asubio Pharma Co., Ltd, Kobe.
  • Yoshikiyo K; Immunology and Inflammatory Disease Field, Asubio Pharma Co., Ltd, Kobe.
  • Maeda H; Immunology and Inflammatory Disease Field, Asubio Pharma Co., Ltd, Kobe.
  • Aoki Y; End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan.
Hum Mol Genet ; 28(1): 74-83, 2019 01 01.
Article in En | MEDLINE | ID: mdl-30239744
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ectodermal Dysplasia / Natriuretic Peptide, C-Type / Proto-Oncogene Proteins B-raf / Failure to Thrive / Heart Defects, Congenital Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ectodermal Dysplasia / Natriuretic Peptide, C-Type / Proto-Oncogene Proteins B-raf / Failure to Thrive / Heart Defects, Congenital Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2019 Document type: Article